首页 | 本学科首页   官方微博 | 高级检索  
     


High [18F] 2-fluoro-2-deoxy-d-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome
Authors:Akiko?Shimizu,Noboru?Oriuchi  mailto:oriuchi@showa.gunma-u.ac.jp"   title="  oriuchi@showa.gunma-u.ac.jp"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Yoshito?Tsushima,Tetsuya?Higuchi,Jun?Aoki,Keigo?Endo
Affiliation:Department of Diagnostic Radiology and Nuclear Medicine, Gunma University School of Medicine Motojima General Hospital, Japan.
Abstract:
A 48-year-old woman with left adrenal tumor, which showed increased uptake of [18F] 2-fluoro-2-deoxy-D-glucose (FDG) was presented. Her adrenal tumor was incidentally discovered, although she had no remarkable illness, and her blood pressure was normal. Hormonal examination including dexamethason suppression test and diurnal variation in serum cortisol level confirmed preclinical Cushing's syndrome. CT, MRI and 131I-adosterol scintigraphy showed findings consistent with adenoma. FDG-PET revealed that tumor had standardized uptake value of 4.8, which was higher than usual benign tumors. Histological diagnosis of the resected adrenal tumor was adrenocortical adenoma without evidence of malignancy. Although the current literature showed that adenomas in general did not exhibit increased FDG uptake, adenoma in the present case with subclinical Cushing's syndrome showed intense uptake of FDG, suggesting FDG-PET could evaluate hormonal function of an adrenocortical adenoma in a completely asymptomatic normocortisolism patient.
Keywords:FDG-PET  preclinical Cushing's syndrome  adrenocortical adenoma  adrenal incidentaloma
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号